RARA CRAFT DATABASE for FDA Medical Devices
510(k)K200072

FDA DEVICE FACTS

KIMTECH Purple Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs, the Opioid Fentanyl, Gastric acid, and Fentanyl in Gastric acid

Kimberly-Clark Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 10, 2020PRODUCT CODELZA

Indications for use

The Nitrile Powder Free patient examination glove is non-sterile disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. Test Results Follow: Chemotherapy Drug Concentration Minimum Breakthrough Detection Time

Blenoxane (15mg/mL),(15,000 ppm) >240 Busulfan (6mg/mL),(6,000 ppm) >240 Carmustine (BiCNU) (3.3mg/mL),(3,300 ppm) >3.6 Cisplatin (lmg/mL),(1,000 ppm) >240 Cyclophosphamide/cytoxan (20mg/mL),(20,000 ppm) >240 Cytarabine (100mg/mL),(100,000 ppm) >240 Dacarbazine(DTIC) (10mg/mL),(10,000 ppm) >240 Daunorubicin (5mg/mL),(5,000 ppm) >240 Docetaxel (10mg/mL),(l 0,000ppm) >240 Doxorubicin (2mg/mL),(2,000 ppm) >240 Ellence (2mg/mL),(2,000 ppm) >240 Etoposide/Toposar (20mg/mL,(20,000 ppm) >240 Fludarabine (25mg/mL),(25,000 ppm) >240 Fluorouracil (50mg/mL),(50,000 ppm) >240 Gemcitabine (38mg/mL),(38,000 ppm) >240 Idarubicin (1mg/mL),(1,000 ppm) >240 Ifosfamide (50mg/mL),(50,000 ppm) >240 Irinotecan (20mg/mL),(20,000 ppm) >240 Mechlorethamine HCL (l mg/mL),(1,000 ppm) >240 Melphalan (5mg/mL),(5,000 ppm) >240 Methotrexate (25mg/mL),(25,000 ppm) >240 Mitomycin C (0.5mg/mL),(500 ppm) >240 Mitoxantrone (2mg/mL),(2,000 ppm) >240 Paclitaxel (6mg/mL),(6,000 ppm) >240 Paraplatin (10mg/mL),(10,000 ppm) >240 Rituximab (10mg/mL),(10,000 ppm) >240 Thiotepa (10mg/mL),(10,000 ppm) >15.9 Trisenox (0.l mg/mL),(100 ppm) >240 Vincristine Sulfate (l mg/ m ),(1,000 ppm) >240

The Fentanyl Citrate and Gastric acid tested as follows: Fentanyl Citrate 100mcg/2mL >240 Gastric Acid (simulated) 0.2% NaCl in 0.7% HCL >240 Fentanyl in Gastric Acid 50/50 Mix >240

Note: Carmustine and Thiotepa have extremely low permeation times of 3.6 and 15.9 minutes respectively Warning: Do Not Use With: Carmustine, Thiotepa

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026